文献速递外周动脉疾病

主髂动脉支架术中血管内超声成像对1年结局无影响

Intravascular Ultrasound Imaging During Aortoiliac Stenting: No Impact on Outcomes at 1 Year.
PubMed 文献 · J Endovasc Ther · 2020-08-19

该回顾性倾向评分匹配分析基于日本OMOTENASHI注册数据库,比较了545例IVUS辅助与258例无IVUS的主髂动脉自膨胀支架植入患者。匹配138对后,两组12个月再狭窄率无显著差异(10.2% vs 10.3%,p=0.99),但IVUS组手术时间和透视时间更长。

要点

  • IVUS辅助主髂动脉支架植入未降低12个月再狭窄率。
  • IVUS组手术时间和透视时间显著更长。
  • 在主髂动脉病变中常规使用IVUS可能不必要。

核心结论

  • 倾向评分匹配分析显示IVUS辅助主髂动脉支架植入的手术时间和透视时间显著长于无IVUS者,但12个月再狭窄率无显著差异。
  • 在主髂动脉病变中使用IVUS可能不必要。

研究设计与样本

  • 回顾性分析源自OMOTENASHI注册数据库,纳入803例有症状PAD患者(Rutherford 2-4级),于2014年1月至2016年4月在日本61个中心接受主髂动脉粥样硬化病变自膨胀支架植入。
  • 545例(67.9%)接受IVUS辅助支架植入,258例无IVUS,进行倾向评分匹配后形成138对匹配队列。

主要发现

  • IVUS组与无IVUS组的血管内治疗策略和术后药物无显著差异。
  • IVUS组手术时间<1小时的比例更低,透视时间更长。
  • 12个月再狭窄率两组无显著差异[10.2%(95%CI 6.9-14.9%)vs 10.3%(95%CI 5.4-18.6%),p=0.99]。
  • 基线特征与IVUS使用和再狭窄风险之间无交互作用。

临床怎么用

  • 对于主髂动脉粥样硬化病变的自膨胀支架植入,IVUS辅助并未改善1年再狭窄率,且延长手术和透视时间,提示可能无需常规使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the effect of intravascular ultrasound (IVUS) imaging use on clinical outcomes after aortoiliac stenting in patients with peripheral artery disease (PAD). MATERIALS AND METHODS: Subjects for this retrospective analysis were derived from the OMOTENASHI registry database, which contained 803 symptomatic PAD patients (Rutherford categories 2-4) who were treated with self-expanding stent implantation for aortoiliac atherosclerotic lesions at 61 centers in Japan between January 2014 and April 2016. Of the 803 patients, 545 (67.9%) patients (mean age 73±9 years; 453 men) underwent IVUS-supported stent implantation and were compared with the 258 patients (mean age 73±8 years; 217 men) treated without IVUS. A propensity score analysis of 138 matched pairs was conducted to compare treatment strategies and clinical outcomes between patients having IVUS-supported endovascular therapy and those treated without IVUS. RESULTS: Endovascular strategies and postoperative medications were not significantly different between the IVUS and no-IVUS groups. A procedure time under 1 hour was less frequent in the IVUS group, which had a longer fluoroscopy time. The 12-month restenosis rate was not significantly different between the 2 groups [10.2% (95% CI 6.9 to 14.9%) vs 10.3% (95% CI 5.4 to 18.6%), p=0.99]. There was no interaction between baseline characteristics and the association of IVUS use with restenosis risk. CONCLUSION: Propensity score matching analysis revealed that duration and fluoroscopy time during IVUS-supported procedures were significantly longer than in cases without IVUS use, whereas the 12-month restenosis rate was not significantly different between the groups. IVUS use in aortoiliac lesions may be unnecessary.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Tsujimura T, Takahara M, Iida O, et al. Intravascular Ultrasound Imaging During Aortoiliac Stenting: No Impact on Outcomes at 1 Year. J Endovasc Ther. 2020. PMID: 32813591. doi:10.1177/1526602820949872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。